Life Sciences Virtual Investor Forum Welcomes Investors
The Life Sciences Virtual Investor Forum is poised to bring together a vibrant community of investors seeking to engage with some of the most pioneering organizations in the life sciences sector. Scheduled for a future date, this event is tailored to accommodate individual investors, institutional investors, advisors, and analysts alike.
Pre-Registration and Participation
Participants are encouraged to pre-register and utilize the online system check aimed at facilitating smooth access to presentations and one-on-one meetings with the management teams of presenting companies. This event is completely free of charge, enabling attendees to enjoy live presentations and critical discussions among esteemed organizations.
Event Highlights and Presenting Companies
Jason Paltrowitz, the Executive Vice President of Corporate Services at OTC Markets Group, expresses excitement over the upcoming forum. "The life sciences sector is innovating at a remarkable pace, and our event gives investors a front-row seat to that momentum." The schedule is lined with engaging presentations from various companies actively advancing in the field.
Detailed Agenda
The event's detailed agenda includes an impressive lineup of presentations, providing insights from diverse players in the life sciences arena:
10:00 AM - Prostatype Genomics AB (OTCQB: PGABF, Nasdaq First North: PROGEN) will kick things off.
11:00 AM - Defence Therapeutics Inc. (OTCQB: DTCFF, CSE: DTC), known for its innovative therapeutic technologies, will follow.
11:30 AM - EcholQ Ltd. (OTCQB: ECHQF, ASX: EIQ) will showcase its developments within the field.
12:00 PM - Thiogenesis Therapeutics Corp. (OTCQX: TTIPF, TSXV: TTI) will provide insights into its revolutionary approaches.
12:30 PM - Genvor Inc. (OTCQB: GNVR) will present its latest advancements.
2:00 PM - InMed Pharmaceuticals Inc. (NASDAQ: INM) will take the stage with updates on its research and development.
2:30 PM - BioCorRx Inc. (OTCQB: BICX) will conclude the day's presentations.
Connecting with Investors
To foster investor relations, the event emphasizes individualized meeting opportunities with management teams to encourage organic dialogue around each company's innovative initiatives. Attendees are expected to gain critical insights that can guide their investment strategies moving forward.
About Virtual Investor Conferences
Virtual Investor Conferences operates as a leading platform where publicly traded companies can directly engage with investors. This format mimics traditional in-person investor conferences while providing enhanced features that include targeted one-on-one meetings and the chance to showcase presentations enriched with dynamic content.
Contact Information
For media inquiries, please reach out to OTC Markets Group Inc. at +1 (212) 896-4428 or contact them via email at media@otcmarkets.com. Additionally, John M. Viglotti from OTC Markets Group serves as the main contact for investor access, available at (212) 220-2221 or via johnv@otcmarkets.com.
Frequently Asked Questions
What is the Life Sciences Virtual Investor Forum?
This forum is an event designed for investors to engage with various companies innovating in the life sciences sector, featuring multiple presentations and networking opportunities.
When will the forum take place?
The specific date of the forum is yet to be announced, but it is anticipated in the near future.
How can I register for the event?
Interested parties can register through the event’s official website, where a registration link will be made available.
Is there a cost to attend the forum?
No, there is no cost associated with logging in or attending live presentations at the forum.
What companies will be presenting?
The event features a variety of companies such as Prostatype Genomics AB, Defence Therapeutics Inc., and more, showcasing their innovations in the life sciences industry.
